Ignite Creation Date:
2024-05-06 @ 6:58 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05856383
Status:
RECRUITING
Last Update Posted:
2023-05-12
First Post:
2023-04-02
Brief Title:
Efficacy and Safety of Inetetamab Combined With Pyrotinib and Vinorelbine in ABC
Sponsor:
Zhejiang Cancer Hospital
Organization:
Zhejiang Cancer Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-16
Start Date Type:
ACTUAL
Primary Completion Date:
2027-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-04-02
First Submit QC Date:
May 3 2023
Study First Post Date:
2023-05-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-03
Last Update Post Date:
2023-05-12
Last Update Post Date Type:
ACTUAL